This company seems to have been delisted
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
PerkinElmer
PKI
$115.24
Share price
-0.91%
Change (1 day)
-27.18%
Change (1 year)
Categories
PerkinElmer, Inc. is an American chemical and medical technology company with operations in environmental health and human health.
EPS for PerkinElmer (PKI)
EPS in 2023 (TTM): $7.70
According to PerkinElmer 's latest financial reports the company's current EPS (TTM) is $7.70. In 2022 the company made an earnings per share (EPS) of $4.59 a decrease over its 2021 EPS that were of $8.13.
EPS history for PerkinElmer from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $7.70 | 67.76% |
| 2022 | $4.59 | -43.54% |
| 2021 | $8.13 | 24.94% |
| 2020 | $6.51 | 217.35% |
| 2019 | $2.05 | -4.84% |
| 2018 | $2.15 | -19.23% |
| 2017 | $2.67 | 24.53% |
| 2016 | $2.14 | 13.35% |
| 2015 | $1.89 | 34.63% |
| 2014 | $1.40 | -4.02% |
| 2013 | $1.46 | 135.06% |
| 2012 | $0.62 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $17.09 | 121.95% | 🇺🇸 USA |
 Waters Corporation WAT | $11.07 | 43.77% | 🇺🇸 USA |
 Agilent Technologies A | $4.07 | -47.14% | 🇺🇸 USA |
 Bruker BRKR | $0.52 | -93.25% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -$76.17 | -1,089.25% | 🇺🇸 USA |
 Becton Dickinson BDX | $5.25 | -31.82% | 🇺🇸 USA |
 Illumina ILMN | -$6.05 | -178.57% | 🇺🇸 USA |